Literature DB >> 15354282

Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.

Shilpa Grover1, Elena M Stoffel, Laoti Bussone, Elizabeth Tschoegl, Sapna Syngal.   

Abstract

BACKGROUND AND AIMS: An accurate family history is an essential component of cancer risk assessment. Our aim was to determine the concordance of family history assessments made by physicians with patients' self-reports and the frequency of referral for genetic evaluation in high-risk colorectal cancer (CRC) patients.
METHODS: A self-administered family cancer history questionnaire was completed by 387 consecutive CRC patients at their first visit to a gastroenterology cancer clinic. Physician notes from the first visit were reviewed to determine the concordance of the family cancer history with patients' self-reported history. Prevalence of individuals that satisfied the Bethesda guidelines for hereditary colon cancer were compared with actual rates of referral. Regression analyses were used to determine factors associated with a comprehensive physician evaluation of family history.
RESULTS: Oncologists documented a comprehensive family history in 59% (184 of 311) of patients with a first- or second-degree relative with cancer. Young age at diagnosis and a first-degree relative with CRC were not associated with a more comprehensive family history assessment. An increasing number of cancers per family was a strong predictor of a less comprehensive family history assessment (odds ratio = 0.63; P < 0.0001). Seventy-five of 387 (19%) CRC patients met Bethesda guidelines for genetics assessment, however, only 13 of 75 (17%) were referred.
CONCLUSIONS: Increased complexity in family cancer history leads to a decrease in accuracy of family history, suggesting the need for systematic approaches to facilitate family history assessment. Familial cancer risk remains largely unrecognized and referral rates for genetic evaluation for CRC syndromes are low.

Entities:  

Mesh:

Year:  2004        PMID: 15354282     DOI: 10.1016/s1542-3565(04)00352-0

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  54 in total

1.  The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program.

Authors:  Aparna Mukherjee; Thomas J McGarrity; Francesca Ruggiero; Walter Koltun; Kevin McKenna; Lisa Poritz; Maria J Baker
Journal:  Hered Cancer Clin Pract       Date:  2010-11-22       Impact factor: 2.857

2.  Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees.

Authors:  Amy S Oxentenko; Robert A Vierkant; Darrell S Pardi; David R Farley; Eric J Dozois; Thomas E Hartman; David M Hough; Wesley O Petersen; Carrie N Klabunde; Katherine Sharpe; John H Bond; Robert A Smith; Bernard Levin; John B Pope; Paul C Schroy; Paul J Limburg
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

Review 3.  History, genetics, and strategies for cancer prevention in Lynch syndrome.

Authors:  Fay Kastrinos; Elena M Stoffel
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

4.  Cancer risk assessment by rural and Appalachian family medicine physicians.

Authors:  Kimberly M Kelly; Margaret M Love; Kevin A Pearce; Kyle Porter; Mary A Barron; Michael Andrykowski
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

5.  Barriers to and motivations for physician referral of patients to cancer genetics clinics.

Authors:  Carrie F Prochniak; Lisa J Martin; Erin M Miller; Sara C Knapke
Journal:  J Genet Couns       Date:  2011-08-13       Impact factor: 2.537

6.  Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.

Authors:  Terri Febbraro; Katina Robison; Jennifer Scalia Wilbur; Jessica Laprise; Amy Bregar; Vrishali Lopes; Robert Legare; Ashley Stuckey
Journal:  Gynecol Oncol       Date:  2015-04-28       Impact factor: 5.482

7.  Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Authors:  Amanda S Bruegl; Bojana Djordjevic; Brittany Batte; Molly Daniels; Bryan Fellman; Diana Urbauer; Rajyalakshmi Luthra; Charlotte Sun; Karen H Lu; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-25

8.  Improving the quality of colorectal cancer screening: assessment of familial risk.

Authors:  Lynn F Butterly; Martha Goodrich; Tracy Onega; Mary Ann Greene; Amitabh Srivastava; Randall Burt; Allen Dietrich
Journal:  Dig Dis Sci       Date:  2010-03       Impact factor: 3.199

9.  Primary care physicians' use of family history for cancer risk assessment.

Authors:  Brian S Flynn; Marie E Wood; Takamaru Ashikaga; Alan Stockdale; Greg S Dana; Shelly Naud
Journal:  BMC Fam Pract       Date:  2010-06-03       Impact factor: 2.497

10.  Improving calculation, interpretation and communication of familial colorectal cancer risk: protocol for a randomized controlled trial.

Authors:  Nicky Dekker; Rosella P M G Hermens; Glyn Elwyn; Trudy van der Weijden; Fokko M Nagengast; Peter van Duijvendijk; Simone Salemink; Eddy Adang; J Han J M van Krieken; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge
Journal:  Implement Sci       Date:  2010-01-28       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.